BullFrog AI

BullFrog AI

Biotech AI

Company website
Foundation year

2020

About

BullFrog AI Holdings, Inc. is an innovative company that uses machine learning and artificial intelligence to develop pharmaceuticals. The company conducts its own research programs on drug molecules across four different areas, but its main market is providing services to external developers, which is valued at over $47 billion.

BullFrog has its own AI/ML platform called bfLEA, which was developed by scientists at Johns Hopkins University. It uses various types of machine learning that are capable of identifying significant relationships between potentially effective molecules and biochemical processes.

One advantage of bfLEA is its ability to work with minimal human involvement and without the need for a prior hypothesis. In other words, bfLEA can work with unprocessed and unlabeled datasets, identifying potentially useful hidden patterns of interaction. This increases the likelihood of discovering fundamentally new directions for treating a variety of diseases.
___________________________

Number of employees:

4-10
___________________________

Headquarters:

Boyd's, Maryland, USA

Underwriters

TEDCO


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.